ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Corticosteroid Nasal Sprays Approved for Over-the-Counter Use

by Mary Beth Nierengarten • September 7, 2014

  • Tweet
  • Email
Print-Friendly Version
Corticosteroid Nasal Sprays Approved for Over-the-Counter Use

In October 2013, the first intranasal corticosteroid nasal spray became available for over-the-counter (OTC) use after the U.S. Food and Drug Administration (FDA) approved Nasacort AQ (triamcinolone acetonide) for the nonprescription treatment of nasal allergy symptoms.

You Might Also Like

  • Irrigations Better Able Than Sprays to Reach Parts of Nasal Cavity
  • Steroidal Sprays for Rhinosinusitis: Experts Assess a Review
  • Treating Allergic Rhinitis: A Patient Experiment
  • A Patient Experiment
Explore This Issue
September 2014

The decision was met with some controversy, most notably in a response from the American Academy of Otolarnygic Allergy (AAOA), the American Academy of Allergy, Asthma and Immunology (AAAAI), and the American College of Allergy, Asthma and Immunology (ACAAI). These organizations submitted their response to the FDA detailing their objections to making these sprays OTC due to safety concerns.

In their response, the AAAAI and ACAAI described updated studies that supported their earlier recommendations against the OTC use of intranasal corticosteroid nasal sprays published in a position paper in 2006 (Ann Allergy Asthma Immunol. 2006;96:514-525). Highlighted in both the position paper and a 2013 response to the FDA decision was the need for clinician monitoring of these sprays to avoid potential adverse effects, including growth suppression in children and ocular side effects and osteoporosis in some individuals.

Bryan Leatherman, MD, secretary of the AAOA board of directors, says his organization expressed concern over ensuring patients were receiving an accurate diagnosis of their nasal problems, were given good information about appropriate treatment options, and that they were monitored long-term for potential side effects.

Another concern is that some patients may not be knowledgeable in how to use the product. “We know that these [medications] are extremely effective, but only when used the right way, and with the knowledge that they only should be used once a day,” said Alpen Patel, MD, who serves as AAOA socioeconomic chair. Also, he said, “they may not use it long enough and may prematurely give up on it.”

Effect on Treatment of Patients

According to Timothy L. Smith, MD, MPH, professor of otolaryngology/head and neck surgery at Oregon Health and Science University in Portland and

ENTtoday editorial board member, the approval of this first intranasal spray for OTC use has occurred too recently to know how it will affect patients and otolaryngology practice. “I don’t think anyone knows yet how this will play out, but it needs to be actively monitored,” he said, adding that the issue of approving these sorts of drugs for OTC use is on his radar screen but that he doesn’t have any immediate concerns about their use.

Pages: 1 2 3 | Single Page

Filed Under: Allergy, Features, Practice Focus Tagged With: allergy, rhinitisIssue: September 2014

You Might Also Like:

  • Irrigations Better Able Than Sprays to Reach Parts of Nasal Cavity
  • Steroidal Sprays for Rhinosinusitis: Experts Assess a Review
  • Treating Allergic Rhinitis: A Patient Experiment
  • A Patient Experiment

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.